Top: (From left, front row) Roberta Gold, Donna Richard, Ricka Fisher, Dalia Hayon, Paulinda Babbini (president), Dr. Sanaz Memarzadeh, Anat Hartenstein and Barbara Javitz and (back row) Debbi Singer, Cathy Gill, Judi Hochman, Dr. Deanna Janzen, Bonnie Beinhorn, Natalie Mignon and Stacy Baker; Photo: Scott Yanofsky; Middle: (From left) Kenneth, Cassedee, Darius, Jason and Moon-Fat Chan, Photo: Courtesy of the Chan family; Bottom: Maggy and Jack Simon, Photo: Courtesy of Maggy and Jack Simon
For the past six years, the Ovarian Cancer Circle/ Inspired by Robin Babbini has hosted the Happily Ever Laughter fundraiser to support the endometrial- and ovarian-cancer research of Dr. Sanaz Memarzadeh (RES ’00, FEL ’03, PhD ’08), professor and gynecologic-cancer surgeon in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA and director of the G.O. Discovery Laboratory in UCLA’s Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research. This year, the event raised $78,000 and, to date, the Circle has contributed $300,000 to Dr. Memarzadeh’s research. Paulinda Schimmel Babbini founded the Circle to honor the memory of her daughter Robin, who lost her life to ovarian cancer at the age of 20.
The Chan family has made a gift of $250,000 to fund pilot research projects in epilepsy, under the direction of Dr. Dawn Eliashiv (FEL ’94), co-director of the Seizure Disorder Center in the UCLA Department of Neurology. Dr. Eliashiv was one of a few clinician-scientists studying the use of magnetoencephalography (MEG) — a neuroimaging technique for mapping brain activity — as a noninvasive tool to localize seizures in the brain and one of the first to capture seizures with MEG. The contribution will advance studies to identify patterns in the hippocampus when a normal brain develops epilepsy and to discover biomarkers, which will aid in the development of novel interventions to prevent epilepsy, using MEG and other approaches.
The David Geffen School of Medicine at UCLA has received a $5-million bequest from the Bobbe Frankenberg Trust. With this meaningful gift, the school established the Bobbe Frankenberg Scholarship. The scholarship will enhance the recruitment and retention of outstanding students and provide needed tuition assistance for UCLA medical students for decades to come. Through her prior giving, the late Bobbe Frankenberg, a UCLA alumna who graduated in 1939, supported the UCLA Stein Eye Institute and the Fowler Museum.
As a loving tribute to his wife Judi, who passed away in September 2015, Roy Kaufman made a combined pledge of $2.2 million to support the research of Dr. Timothy Cloughesy (RES ’91, FEL ’92), director of UCLA’s Neuro-Oncology Program. After her cancer diagnosis, Judi Kaufman — an artist, writer and gourmet cook — founded Art of the Brain to empower other brain-cancer patients and raise funds for research. Through her leadership, Art of the Brain has raised more than $7 million to date, enabling UCLA to play an integral role in recent advances in brain-cancer investigations. The current gifts will name the Judi Kaufman Gallery in 200 UCLA Medical Plaza — Peter Morton Medical Building, and the Judi Kaufman Lobby in the UCLA Reed Neurological Research Center. Sadly, Roy Kaufman passed away on September 21, 2016.
The UCLA Brain Research Institute has received a distribution of $582,000 from the UCLA Foundation Knaub Unitrust, established by Richard and Suzzanne Knaub to fund multiple sclerosis research. The Jonsson Comprehensive Cancer Center also received a $582,000 distribution from the Unitrust, which will support breast-cancer research and the development of better treatment options for breast cancer.
Barbara and John P. McLoughlin have pledged $1 million to support the development of the Cognitive Health Clinic and research initiatives under the direction of Dr. David Merrill (RES ’09, FEL ’10) in the UCLA Longevity Center — part of the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA — and the Division of Geriatric Psychiatry in the David Geffen School of Medicine at UCLA. This gift will help provide innovative care and assistance to patients by finding new ways to improve the diagnosis and treatment of memory disorders, late-life depression and age-related diseases.
Susan and Bruce Ruehl have made a $500,000 contribution to the Department of Neurology in the David Geffen School of Medicine at UCLA. The gift will fund a five-year ataxia with oculomotor apraxia type 2 (AOA2) study, under the direction of Dr. Brent Fogel (RES ’07, FEL ’09), to identify crucial genetic pathways in AOA2 as potential therapeutic targets. This support enables Dr. Fogel and his team to explore new frontiers in brain science and accelerate investigations that enhance the understanding of AOA2.
The UCLA Department of Neurosurgery received a planned gift of $500,000 from Maggy and Jack Simon to support research for the diagnosis and treatment of vascular malformations of the brain, under the direction of Dr. Neil A. Martin, chair of the Department of Neurosurgery and W. Eugene Stern Chair in Neurosurgery. In recognition of the Simons’s philanthropic commitment, UCLA has named a patient-examination room on the fourth floor of the Edie & Lew Wasserman Building the John B. “Jack” & Maggy Simon Patient Examination Room. Jack Simon is a founding member of the UCLA Department of Neurosurgery Advisory Board.
A commitment of $150,000 from Mari and Randy Tamura has established the Mari and Randall Tamura Pulmonary Research Fund in the UCLA Division of Pulmonary and Critical Care Medicine. The endowed fund will provide sustained support for lung-transplant research, with the ultimate goal of eliminating organ rejection following transplantation.
The UCLA Division of Pulmonary and Critical Care Medicine has benefited from a $250,000 pledge from Susan Bay Nimoy and the late Leonard Nimoy. The contribution will establish the Leonard Nimoy COPD Research Fund and provide significant resources for Dr. John Belperio’s research into chronic obstructive pulmonary disease (COPD).
For more information, contact Health Sciences Development at: (844) 474-4387